InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Woodhouse David J, Chairman & CEO. Insider active across 1 company, notably NGM Biopharmaceuticals INC. In total, 5 filings have been published. Activity tracked since 18 November 2021. The latest transaction was filed on 16 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Woodhouse David J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
23,993 sharesCommon StockSEC:0000950170-24-042609:0
13,032 shares@ US$1.344.1% of flowCommon StockSEC:0001415889-24-001541:0
127,200 shares0Common StockSEC:0001209191-23-016396:0
12,987 shares@ US$7.7043.3% of flowCommon StockSEC:0001209191-21-071613:0
15,000 shares@ US$7.5448.9% of flowCommon StockSEC:0001209191-21-065973:0
5 of 5 declarations
About Woodhouse David J
David J. Woodhouse is the CEO of NGM Biopharmaceuticals Inc. He leads the company with a vision focused on innovation in the biopharmaceutical sector. His experience is essential for strategic development.
